News & Press
Patient Comments Needed For FDA Hearing on Tanning Beds
The National Council on Skin Cancer Prevention (NCSCP) asks patients to submit comments in advance of a FDA hearing to review current classification or regulatory controls of tanning beds. Patients are encouraged to join the conversation by sharing their personal stories that connect the dangers of indoor tanning with skin cancer.
Recent research has shown that using tanning beds before age 35 increases your risk of developing melanoma by 75 percent and occasionally using tanning beds can triple your chances. In fact, the International Agency for Research on Cancer (IARC), part of the World Health Organization recently reclassified tanning devices into the highest risk category as “carcinogenic to humans.”
Recent research has shown that using tanning beds before age 35 increases your risk of developing melanoma by 75 percent and occasionally using tanning beds can triple your chances. In fact, the International Agency for Research on Cancer (IARC), part of the World Health Organization recently reclassified tanning devices into the highest risk category as “carcinogenic to humans.”
Patients can submit written or electronic comments to the FDA by March 19, 2010. The hearing will take place on March 25, 2010 in Gaithersburg, Md.
Submit electronic comments to https://www.regulations.gov and enter ID Number: FDA-2009-N-0606. Duplicate copies should also be sent to Tim Turnham, executive director of the Melanoma Research Foundation at [email protected].
Submit written comments to:
Division of Dockets Management
Docket Number FDA-2009-N-0606
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
Division of Dockets Management
Docket Number FDA-2009-N-0606
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
More information about the hearing is available at: https://www.fda.gov/AdvisoryCommittees/Calendar/ucm190824.htm
Bulletin Board:
Patient Comments Needed For FDA Hearing on Tanning Beds
Urgent request from the FDA! The FDA will be reviewing current warnings and regulations for tanning beds during a March 25th hearing. On behalf of the MRF, we are asking melanoma survivors to submit their personal stories that connect the dangers of indoor tanning with skin cancer. Submissions are due by March 19. You can do this online or through the mail, by visiting https://www.regulations.gov (ID number: FDA-2009-N-0606) or mailing to:
Division of Dockets Management
Docket Number FDA-2009-N-0606
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
Docket Number FDA-2009-N-0606
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
Duplicate copies should also be sent to Tim Turnham, executive director of the Melanoma Research Foundation at [email protected].
See more info here: https://www.fda.gov/AdvisoryCommittees/Calendar/ucm190824.htm